Tu
Non verificato

Tune Therapeutics

Di cosa scriviamo

BiotecnologiaHIV, AIDS e malattie autoimmuniIndustriaMedicina - VarieSalute
13/01/2025
Industria
Scienza
Biologia
Biotecnologia
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Tune Therapeutics Completes Over $175M in Series B Financing to Advance Field-Leading Epigenome Editing Programs
1.00
07/01/2025
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Biologia
Sanità
Salute
Tune Therapeutics Receives Approval to Initiate Clinical Trial in Hong Kong for HepB Epigenetic Silencer
1.00
19/11/2024
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Sanità
Salute
Industria
AASLD 2024: Tune Therapeutics Shows Near-Complete HepB Virus Repression with Tune-401 Epigenetic Silencer
1.00
14/11/2024
Scienza
HIV, AIDS e malattie autoimmuni
Biotecnologia
Medicina - Varie
Sanità
Salute
Industria
Tune Therapeutics Moves into Clinical Spotlight with TUNE-401: A First-in-Class Epigenetic Silencer for Hepatitis B
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0